215 related articles for article (PubMed ID: 10478243)
21. Early MR lymphography with gadofluorine M in rabbits.
Misselwitz B; Platzek J; Weinmann HJ
Radiology; 2004 Jun; 231(3):682-8. PubMed ID: 15163808
[TBL] [Abstract][Full Text] [Related]
22. Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points.
Mehta MP; Shapiro WR; Glantz MJ; Patchell RA; Weitzner MA; Meyers CA; Schultz CJ; Roa WH; Leibenhaut M; Ford J; Curran W; Phan S; Smith JA; Miller RA; Renschler MF
J Clin Oncol; 2002 Aug; 20(16):3445-53. PubMed ID: 12177105
[TBL] [Abstract][Full Text] [Related]
23. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
[TBL] [Abstract][Full Text] [Related]
24. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
[TBL] [Abstract][Full Text] [Related]
25. MR imaging response of brain metastases after gamma knife stereotactic radiosurgery.
Peterson AM; Meltzer CC; Evanson EJ; Flickinger JC; Kondziolka D
Radiology; 1999 Jun; 211(3):807-14. PubMed ID: 10352610
[TBL] [Abstract][Full Text] [Related]
26. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging.
Mayr NA; Yuh WT; Zheng J; Ehrhardt JC; Magnotta VA; Sorosky JI; Pelsang RE; Oberley LW; Hussey DH
AJR Am J Roentgenol; 1998 Jan; 170(1):177-82. PubMed ID: 9423627
[TBL] [Abstract][Full Text] [Related]
27. Multiple cerebral metastases: detectability with Gd-DTPA-enhanced MR imaging.
Russell EJ; Geremia GK; Johnson CE; Huckman MS; Ramsey RG; Washburn-Bleck J; Turner DA; Norusis M
Radiology; 1987 Dec; 165(3):609-17. PubMed ID: 3317495
[TBL] [Abstract][Full Text] [Related]
28. Half-dose gadolinium-enhanced MR imaging with magnetization transfer technique in brain tumors: comparison with conventional contrast-enhanced MR imaging.
Han D; Chang KH; Han MH; Cho JY; Han SW; Kim HD; Seong SO
AJR Am J Roentgenol; 1998 Jan; 170(1):189-93. PubMed ID: 9423630
[TBL] [Abstract][Full Text] [Related]
29. Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine.
Anzalone N; Gerevini S; Scotti R; Vezzulli P; Picozzi P
Acta Radiol; 2009 Oct; 50(8):933-40. PubMed ID: 19626475
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
Svaland MG; Christensen T; Lundorf E
Acta Radiol; 1994 Jul; 35(4):396-9. PubMed ID: 8011392
[TBL] [Abstract][Full Text] [Related]
31. Serial MR imaging of intracranial metastases after radiosurgery.
Hawighorst H; Essig M; Debus J; Knopp MV; Engenhart-Cabilic R; Schönberg SO; Brix G; Zuna I; van Kaick G
Magn Reson Imaging; 1997; 15(10):1121-32. PubMed ID: 9408133
[TBL] [Abstract][Full Text] [Related]
32. Assessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results.
Essig M; Waschkies M; Wenz F; Debus J; Hentrich HR; Knopp MV
Radiology; 2003 Jul; 228(1):193-9. PubMed ID: 12832582
[TBL] [Abstract][Full Text] [Related]
33. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
Sinitsyn VE; Kornienko VN; Nikitin VG; Pronin IN; Ternovoĭ SK; Tiutin LA; Iakobson MG
Vestn Rentgenol Radiol; 1995; (4):5-11. PubMed ID: 8571538
[TBL] [Abstract][Full Text] [Related]
34. Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases.
Kocher M; Eich HT; Semrau R; Güner SA; Müller RP
Strahlenther Onkol; 2005 Jan; 181(1):20-5. PubMed ID: 15660189
[TBL] [Abstract][Full Text] [Related]
35. Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging?
Hamm B; Mahfouz AE; Taupitz M; Mitchell DG; Nelson R; Halpern E; Speidel A; Wolf KJ; Saini S
Radiology; 1997 Mar; 202(3):677-82. PubMed ID: 9051015
[TBL] [Abstract][Full Text] [Related]
36. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
Low RN; Barone RM; Lacey C; Sigeti JS; Alzate GD; Sebrechts CP
Radiology; 1997 Aug; 204(2):513-20. PubMed ID: 9240546
[TBL] [Abstract][Full Text] [Related]
37. Assessment of breast cancer with dynamic gadolinium-enhanced MR imaging combined with magnetization transfer contrast using a newly developed breast surface coil for the supine position.
Shimada M; Senoo A; Hayashi S; Moriya H; Nanba T; Kogure T; Nakayama H; Nakagome M; Ito K; Kaneko I; Tsubuku M
Radiat Med; 1997; 15(2):85-90. PubMed ID: 9192432
[TBL] [Abstract][Full Text] [Related]
38. MR Gd-DTPA enhancement of radiation brain injury.
Nishimura R; Takahashi M; Morishita S; Sumi M; Uozumi H; Sakamoto Y
Radiat Med; 1992; 10(3):109-16. PubMed ID: 1509102
[TBL] [Abstract][Full Text] [Related]
39. An assessment of the effectiveness of magnetic resonance imaging in delayed sequences after administration of Gd-DTPA contrast in the detection of metastatic lesions in the brain.
Grzesiakowska U; Tacikowska M
Med Sci Monit; 2002 Jan; 8(1):MT21-4. PubMed ID: 11782684
[TBL] [Abstract][Full Text] [Related]
40. Detection of brain metastasis: comparison of Turbo-FLAIR imaging, T2-weighted imaging and double-dose gadolinium-enhanced MR imaging.
Okubo T; Hayashi N; Shirouzu I; Abe O; Aoki S; Wada A; Ohtomo K; Sasaki Y
Radiat Med; 1998; 16(4):273-81. PubMed ID: 9814422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
